phone+44 203 371 1100

Baxter International Inc.

Credit Sector:- Health Care

Country:- United States

Bond Document:- https://www.bondpdf.com

In order to view the complete data, please login here

List of Corporate Actions

Announcement Date CA Type CA Impact CA Event ISIN
02-Oct-2023 Sell Subsidiary Target Name Baxter Oncology GmbH US00214WAE12
Baxter International Inc. today announced that it has sold its Baxter Oncology GmbH to Bamboo US BidCo LLC.
02-Oct-2023 Sell Subsidiary Target Name Baxter Pharmaceutical Solutions LLC US00214WAE12
Baxter International Inc. today announced that it has sold its Baxter Pharmaceutical Solutions LLC to Bamboo US BidCo LLC.
02-Oct-2023 Asset Sale - - US00214WAE12
Baxter International Inc. has today announced that it has sold BioPharma Solutions (BPS) business.
01-Dec-2023 Final Maturity - - US071813CY30
Baxter International Inc. today announced that the bond has reached its full maturity for USD 300MM, Floating rate bond due 01-Dec-2023.
01-Dec-2023 Final Maturity - - USU07181BH90
Baxter International Inc. today announced that the bond has reached its full maturity for USD 300MM, Floating rate bond due 01-Dec-2023.

View more details

FactEntry

All of the financial data available on this page is sourced from FactEntry.